Remote Guided Caffeine Reduction
Public ClinicalTrials.gov record NCT04560595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04560595
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Johns Hopkins University
- Other
- Enrollment
- 109 participants
Conditions and interventions
Conditions
- Anxiety
- Anxiety Disorders
- Caffeine
- Caffeine Abuse
- Caffeine Dependence
- Caffeine Withdrawal
- Caffeine-Induced Anxiety Disorder
- Caffeine-Induced Sleep Disorder, Without Use Disorder
- Caffeine; Sleep Disorder
- Diarrhea
- Gastrointestinal Dysfunction
- Heartburn
- Insomnia
- Sleep Disorder
- Sleep Disturbance
- Sleep Initiation and Maintenance Disorders
Interventions
- Caffeine Reduction Manual Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2020
- Primary completion
- Jul 31, 2023
- Completion
- Sep 30, 2023
- Last update posted
- Jan 13, 2025
2020 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04560595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04560595 live on ClinicalTrials.gov.